Please login to the form below

Not currently logged in
Email:
Password:

Roche sues Dr Reddy's over Boniva for osteoporosis

Roche is taking legal action against Indian generic manufacturer Dr Reddy's Laboratories in the US to prevent the Indian's pharma group from marketing a generic version of osteoporosis drug Boniva

Swiss-based pharmaceutical company Roche is taking legal action against Indian generic manufacturer Dr Reddy's Laboratories in the US to prevent the Indian's pharma group from marketing a generic version of Roche's osteoporosis drug Boniva (ibandronate).

The complaint was filed on 20 September in a New Jersey court. Roche says that Boniva is covered by patents running from 2012 to 2023.

In a statement, Roche said: "This action arises because of Dr Reddy's efforts to gain approval from the FDA to market a generic copy of Roche's Boniva once-monthly drug product prior to the expiration of Roche's patent rights covering it."

Earlier in September, Roche initiated legal action against Israel-headquartered generics giant Teva Pharmaceutical's move to enter the US market with a Boniva copy.

Boniva, which is sold under the name of Bonviva in the EU, racked up sales of CHF 488m in FY06.

25th September 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...

Infographics